The Role of Pharmacoepidemiology in the Healthcare System and Academia
Year: 2019
Type: other
Abstract: Once a small, arcane discipline at the fringes of both epidemiology and pharmacology, pharmacoepidemiology has emerged as a central discipline for the healthcare delivery system and in academic medical centers. As records of healthcare interactions and transactions are increasingly captured digitally, pharmacoepidemiology has become a key tool for turning these real-world data into evidence that can be used to inform clinical, regulatory, and policy decisions. Such data are analyzed by increasingly powerful software and hardware, combined with increasingly advanced epidemiologic and analytic methods. Beyond defining the benefits and risks of therapeutics, these tools can point to how best to maximize benefits, reduce risks, and contain costs for populations as well as for specific groups of individuals. The perspective of pharmacoepidemiology is likely to become increasingly more central as regulators move toward adaptive drug approval processes, which are intended to offer earlier and more progressive patient access to new medications, and as learning healthcare systems, in which the data generated within a medical center are analyzed and used to improve delivery of care within the system, continue to grow.
Source: Pharmacoepidemiology
Authors: Joshua J. Gagne, Jerry Avorn
Institutions: Brigham and Women's Hospital, Harvard University
Language: English
Subfield: Geriatrics and Gerontology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,207
OpenAlex ID: W4236164441